Found 77 matching trials
Neo-TACE-HAIC for BCLC B Stage HCC NA Hepatocellular carcinoma (HCC) patients is a common disease in the East Asi...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT N/A This multicenter retrospective study evaluated consecutive patients with la...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma PHASE1 This study is designed to evaluate the efficacy and safety of sintilimab-be...
Show More Location
Multiple Locations
Learn More & Join Trial
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT PHASE2 This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC PHASE3 The purpose of this study is to evaluate the efficacy and safety of hepatic...
Show More Location
Dongguan People's Hospital
Learn More & Join Trial
HAIC+Lenvatinib+Tislelizumab vs D-TACE+Lenvatinib+Tislelizumab for Unresectable HCC PHASE2 Drug-eluting Bead-Transarterial chemoembolization (D-TACE) is the most wide...
Show More Location
The Second Affiliated Hospital of Nanchang University
Learn More & Join Trial
HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven) PHASE3 The purpose of this prospective, randomized, multicenter, controlled clinic...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver Metastases N/A Both drug-eluting bead transarterial chemoembolization (DEB-TACE) and hepat...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma PHASE2 Purpose: This phase II clinical trial evaluates whether a combination of li...
Show More Location
Multiple Locations
Learn More & Join Trial
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC PHASE2 The purpose of the study is to observe the effect of TACE/HAIC combined wit...
Show More Location
Third Affiliated Hospital, Sun Yat-Sen University
Learn More & Join Trial